Webinar: Dystrophic Epidermolysis Bullosa
Sponsored Webinar: When a Blister is More than it First Appears: Dystrophic Epidermolysis Bullosa and the Case for Diagnostic Vigilance featuring Lawrence F. Eichenfield, MD.
Dystrophic Epidermolysis Bullosa (DEB), a form of Epidermolysis Bullosa (EB), is a serious genetic blistering disorder. Due to overlap in symptoms with other EB types and other non-EB blistering disorders, a DEB diagnosis can be delayed or missed. However, DEB has unique complications and risks and requires vigilance and proactive care. At this webinar, we will share an overview of DEB, its signs and symptoms, complications, and ways to diagnose and manage it.
This webinar is intended for PeDRA Active, Affiliate, and Trainee members and health care providers only.
When a Blister is More than it First Appears: Dystrophic Epidermolysis Bullosa and the Case for Diagnostic Vigilance
Sponsored by Krystal Biotech, Inc.
Recorded Live Thursday, July 14, 2022 at 5:30 PM PT / 8:30 PM ET
Speaker: Lawrence F. Eichenfield, MD
Lawrence F. Eichenfield, MD
Distinguished Professor of Dermatology and Pediatrics
Vice Chair, Department of Dermatology
Chief, Pediatric and Adolescent Dermatology
University of California, San Diego School of Medicine and
Rady Children’s Hospital, San Diego
Founding Member of the Pediatric Dermatology Research Alliance
This program is hosted by the Pediatric Dermatology Research Alliance (PeDRA). This is not CME-accredited.
PeDRA will evaluate content for suitability for its audience but is not responsible for the creation of content, selection of speakers, or delivery of presentations. Please email us at info@pedraresearch.org with any questions or concerns.
